Clinical Trial Evidence Supporting FDA Approval of Drugs Granted Breakthrough Therapy Designation

JAMA - Journal of the American Medical Association- United States

doi 10.1001/jama.2018.7619

Full Text

Abstract

Available in

Categories

Medicine

Date

Authors

Publisher

American Medical Association (AMA)

Related search

FDA Approval of Obesity Drugs

JAMA - Journal of the American Medical Association
Medicine
2012English

FDA Approval of New Drugs

JAMA - Journal of the American Medical Association
Medicine
2014English

Breakthrough Therapy Status €“ Expedited FDA Regulatory Approval but What About the Payers?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Registration, Results Reporting, and Publication Bias of Clinical Trials Supporting FDA Approval of Neuropsychiatric Drugs Before and After FDAAA: A Retrospective Cohort Study

Trials
MedicinePharmacology
2018English

FDA Oversight of Cell Therapy Clinical Trials

Science Translational Medicine
Medicine
2012English

Obinutuzumab Breaks Through to FDA Approval

Cancer Discovery
Oncology
2013English

From the FDA: Expanded Use Granted for Implantable Defibrillators

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1996English

How to Design a Cell or Gene Therapy Clinical Trial: Advice From the FDA

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Analysis of FDA Approved Anticancer Drugs Reveals the Future of Cancer Therapy

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy